Molecular measurable residual disease testing of blood during AML cytotoxic therapy for early prediction of clinical response published as: https://t.co/M5bFnQBuA5 @FrontOncology #biorxiv
3,061 followers
1,240 followers
6,535 followers
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response: Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami,… https
36 followers